+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 25Years
All Genders
ID07585136

Evaluating Safety and Collection of Stem Cells Using Filgrastim and Plerixafor for Bone Marrow Failure Syndromes

Led by St. Jude Children's Research Hospital · Updated on 2026-10-06

12

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and feasibility of using Filgrastim combined with plerixafor to mobilize and collect hematopoietic stem and progenitor cells HSPCs in patients with bone marrow failure syndromes BMFS. This phase I, open-label study aims to advance gene therapy by collecting these cells safely from participants with life-threatening blood disorders. The study primarily focuses on monitoring adverse events and measuring the mobilization and collection efficiency of CD34 cells. Participants will receive Filgrastim injections twice daily for five days, followed by a single dose of plerixafor on the fifth day. About four to five hours after plerixafor administration, HSPCs will be collected via apheresis using either peripheral venous access or a central venous catheter. Part of the collected cells will be stored for potential future gene therapy, while the rest will be used for research. The study consists of a screening period, an intervention period for mobilization and apheresis, and outpatient follow-up. During the study, participants will undergo laboratory tests, physical exams, and bone marrow evaluations before mobilization, with additional follow-up visits within 7 to 10 days post-intervention and a telephone follow-up about 30 days later. A final bone marrow evaluation will occur within six months after the procedure. Researchers will track safety by recording adverse events and assess the effectiveness of cell mobilization by measuring CD34 cell counts and yields. The total participation duration includes screening, treatment, and follow-up phases.

CONDITIONS

Brief Title

Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders

Research Team

A

Alexis Leonard, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here